エレトリプタン
Sign in to saveAlso known as UK 116044
Eletriptan, sold under the brand name Relpax and used in the form of eletriptan hydrobromide, is a second-generation triptan medication intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer.
Research
323 papers- Eletriptan.2006
- Eletriptan.Expert opinion on drug metabolism & toxicology · 2009
- Eletriptan.Expert opinion on investigational drugs · 2001
- Eletriptan.2026
- Eletriptan review.Expert opinion on pharmacotherapy · 2005
via PubMed
Wikidata facts
- Mass
- 382.171499
- Has use
- medication
Show 9 more facts
- medical condition treated
- migraine
- chemical formula
- C₂₂H₂₆N₂O₂S
- significant drug interaction
- linezolid
- isomeric SMILES
- CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
- canonical SMILES
- CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
- World Health Organisation international non-proprietary name
- eletriptan
- defined daily dose
- 40
- subject has role
- serotonin receptor agonists
- Commons category
- Eletriptan
Sources (3)
via Wikidata · CC0
Available in 11 languages
via Wikidata sitelinks · CC0